Healthleap raises $38M for its AI that flags hospital patients who may need a closer look

Your hospital bills may soon reflect earlier identification of conditions like malnutrition or delirium. The software is designed to improve patient outcomes and reduce lengths of stay, which financially benefits hospitals through increased reimbursement and cost savings.

Healthleap, a startup focused on using artificial intelligence to identify at-risk hospital patients, has secured $38 million in seed and Series A funding. The funding round was co-led by Sequoia Capital and First Round Capital for the seed portion, with Hummingbird Ventures leading the Series A. Founded in 2022, Healthleap's AI platform analyzes patient electronic health records, including unstructured clinical notes, to flag individuals potentially suffering from conditions like malnutrition or delirium that may be overlooked. The platform is currently used in over 50 hospitals, including major institutions like Penn Medicine and Cedars-Sinai, to identify risks for conditions such as aspiration pneumonia and pressure ulcers. Healthleap also aims to predict readmission risks for congestive heart failure. The company states its software highlights potential issues for clinician review rather than diagnosing patients. Healthleap has reported significant revenue growth and substantial financial returns for its hospital partners, attributing this to improved patient outcomes and increased reimbursement.

This funding round signals continued investor confidence in AI's ability to optimize hospital operations and patient care by uncovering hidden risks within existing electronic health records. The focus on extracting insights from unstructured clinical notes suggests a move towards more comprehensive AI analysis that can supplement structured data, potentially leading to earlier interventions for a wider range of conditions beyond initial targets like malnutrition.

The success and reported ROI of Healthleap's outcome-based pricing model could encourage similar startups and health systems to explore value-based contracts for AI solutions. This approach ties vendor success directly to demonstrable financial and clinical improvements for hospitals, aligning incentives and potentially accelerating adoption of AI tools that prove their worth through hard metrics.